Brian Liu

Director at CG Oncology

Brian Liu, MD, is a Principal at Longitude Capital. Dr. Liu is a board observer at Quanta Therapeutics and Rivus Pharmaceuticals. He previously served as a board observer at Endeavor Biomedicines, Inflazome (acquired by Roche), Talaris Therapeutics (TALS), and Vera Therapeutics (VERA). Prior to joining Longitude Capital in 2018, Dr. Liu was an Engagement Manager in the pharmaceuticals practice of McKinsey & Company. Dr. Liu holds an MD from Stanford School of Medicine and a BS in Biomedical Engineering from Johns Hopkins University.

Location

Stanford, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


CG Oncology

1 followers

CG Oncology is a clinical-stage biotechnology company focused on developing the next evolution of oncolytic immunotherapy for patients with advanced cancer.


Industries

Employees

11-50

Links